These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 37242525)
1. Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression. Borsellino P; Krider RI; Chea D; Grinnell R; Vida TA Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242525 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of ketamine action as an antidepressant. Zanos P; Gould TD Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791 [TBL] [Abstract][Full Text] [Related]
3. Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant. Xu S; Yao X; Li B; Cui R; Zhu C; Wang Y; Yang W Front Pharmacol; 2021; 12():740996. PubMed ID: 35872836 [TBL] [Abstract][Full Text] [Related]
4. Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine. Deyama S; Kaneda K Neuropharmacology; 2023 Feb; 224():109335. PubMed ID: 36403852 [TBL] [Abstract][Full Text] [Related]
5. Arketamine, a new rapid-acting antidepressant: A historical review and future directions. Zhang JC; Yao W; Hashimoto K Neuropharmacology; 2022 Nov; 218():109219. PubMed ID: 35977629 [TBL] [Abstract][Full Text] [Related]
6. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine. Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718 [TBL] [Abstract][Full Text] [Related]
7. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761 [TBL] [Abstract][Full Text] [Related]
9. Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine's Antidepressant Action. Aleksandrova LR; Wang YT; Phillips AG Chronic Stress (Thousand Oaks); 2017; 1():. PubMed ID: 30556028 [TBL] [Abstract][Full Text] [Related]
10. The role of eEF2 kinase in the rapid antidepressant actions of ketamine. Suzuki K; Monteggia LM Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacology of ketamine and esketamine as rapid-acting antidepressants]. Pavlidi P; Megalokonomou A; Sofron A; Kokras N; Dalla C Psychiatriki; 2021 Dec; 32(Supplement I):55-63. PubMed ID: 34990380 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor. Wei Y; Chang L; Hashimoto K Mol Psychiatry; 2022 Jan; 27(1):559-573. PubMed ID: 33963284 [TBL] [Abstract][Full Text] [Related]
13. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective. Hashimoto K Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725 [TBL] [Abstract][Full Text] [Related]
14. Ketamine: The final frontier or another depressing end? Sial OK; Parise EM; Parise LF; Gnecco T; Bolaños-Guzmán CA Behav Brain Res; 2020 Apr; 383():112508. PubMed ID: 32017978 [TBL] [Abstract][Full Text] [Related]
15. Ketamine and its metabolites: Potential as novel treatments for depression. Zhang K; Yao Y; Hashimoto K Neuropharmacology; 2023 Jan; 222():109305. PubMed ID: 36354092 [TBL] [Abstract][Full Text] [Related]
16. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition. Miller OH; Moran JT; Hall BJ Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972 [TBL] [Abstract][Full Text] [Related]
17. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Iadarola ND; Niciu MJ; Richards EM; Vande Voort JL; Ballard ED; Lundin NB; Nugent AC; Machado-Vieira R; Zarate CA Ther Adv Chronic Dis; 2015 May; 6(3):97-114. PubMed ID: 25954495 [TBL] [Abstract][Full Text] [Related]
18. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Deyama S; Duman RS Pharmacol Biochem Behav; 2020 Jan; 188():172837. PubMed ID: 31830487 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Hashimoto K Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141 [TBL] [Abstract][Full Text] [Related]
20. A Review of the Mechanism of Antagonism of N-methyl-D-aspartate Receptor by Ketamine in Treatment-resistant Depression. Sattar Y; Wilson J; Khan AM; Adnan M; Azzopardi Larios D; Shrestha S; Rahman Q; Mansuri Z; Hassan A; Patel NB; Tariq N; Latchana S; Lopez Pantoja SC; Vargas S; Shaikh NA; Syed F; Mittal D; Rumesa F Cureus; 2018 May; 10(5):e2652. PubMed ID: 30034974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]